Combination Therapy with Reovirus and ATM Inhibitor Enhances Cell Death and Virus Replication in Canine Melanoma

Oncolytic virotherapy using reovirus is a promising new anti-cancer treatment with potential for use in humans and dogs. Because reovirus monotherapy shows limited efficacy in human and canine cancer patients, the clinical development of a combination therapy is necessary. To identify candidate comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Igase, Masaya, Shibutani, Shusaku, Kurogouchi, Yosuke, Fujiki, Noriyuki, Hwang, Chung Chew, Coffey, Matt, Noguchi, Shunsuke, Nemoto, Yuki, Mizuno, Takuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804779/
https://www.ncbi.nlm.nih.gov/pubmed/31650025
http://dx.doi.org/10.1016/j.omto.2019.08.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804779/
https://www.ncbi.nlm.nih.gov/pubmed/31650025
http://dx.doi.org/10.1016/j.omto.2019.08.003

Ejemplares similares